George Belendiuk - Concepedia

Author

George Belendiuk

United States Food and Drug Administration

Also Known As

G. Belendiuk, G. W. Belendiuk, G.W Belendiuk, GEORGE BELENDIUK, GEORGE W. BELENDIUK, George Belendiuk, George W. Belendiuk

Publications

840

Citations

H-Index

Concepts

All Affiliations

United States Food and Drug Administration

About

George Belendiuk is an author at United States Food and Drug Administration specializing in medicine, neuropharmacology, and social sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	117
2	Social Sciences	3	3	93
3	Neuroscience	3	3	93
4	Pharmacology	3	3	97
5	Neurology	2	2	44

George Belendiuk

Publications

769

Citations

H-Index

Page 1

	Year	Citations
Preliminary Results of a Double-Blind, Randomized, Placebo-Controlled Trial of Cyclosporine in Myasthenia Gravis Richard S. A. Tindall, JULIA A. ROLLINS, J. Theodore Phillips, New England Journal of Medicine	1987	388
The Treatment of Neurosarcoidosis With Cyclosporine Barney J. Stern, Steven A. Schonfeld, C. Sewell, Archives of Neurology	1992	98
A Double-blind Study of the Effectiveness of Cyclosporine in Amyotrophic Lateral Sclerosis Stanley H. Appel, Scott Stewart, Vicki Appel, Archives of Neurology	1988	96
Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats Samarthji Lal, Theodore L. Sourkes, Krystyna Missala, European Journal of Pharmacology Substance AbusePsychoactive DrugAddictionEmetine AlkaloidsMedicine	1972	51
Pharmacokinetic Evaluation of Twice‐Daily Extended‐Release Carbamazepine (CBZ) and Four‐Times‐Daily Immediate‐Release CBZ in Patients with Epilepsy William R. Garnett, Benjamin Levy, Angus M. McLean, Epilepsia	1998	42
Six-month evaluation of Carbatrol (extended-release carbamazepine) in complex partial seizures Waqar Mirza, Ihor W Rak, Vijay M. Thadani, Neurology Controlled-release Capsule FormMedicineExtended-release CarbamazepineComplex Partial SeizuresGood Seizure Control	1998	24
Plasma butyrylcholinesterase activity and cocaine half-life differ significantly in rhesus and squirrel monkeys Gilberto N. Carmona, Ira Baum, Charles W. Schindler, Life Sciences Psychoactive DrugMedicinePhysiologyPlasma Butyrylcholinesterase ActivityPsychopharmacology	1996	22
Neurotransmitter Abnormalities in Patients With Motor Neuron Disease Katherine A. Belendiuk, George Belendiuk, Daniel X. Freedman, Archives of Neurology Motor DysfunctionMotor Neuron DiseaseNeurological DisorderPlatelet Mao ActivitySocial Sciences	1981	20
Butyrylcholinesterase: an enzyme antidote for cocaine intoxication Carol E. Mattes, George Belendiuk, Thomas J. Lynch, Addiction Biology	1998	18
Neuroperformance Evaluation of Multiple Sclerosis Disease Progression in a Clinical Trial: Implications for Neurological Outcomes Karl Syndulko, W. W. Tourtellotte, Robert W. Baumhefner, Neurorehabilitation and neural repair	1993	10

Page 1